José Ignacio Casal Selected Research

antigastrin

5/2008

Designing antibodies for the inhibition of gastrin activity in tumoral cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José Ignacio Casal Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 01/2005
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2008
2	Neuroblastoma 01/2022 - 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Pathologic Processes 02/2020
1	Obesity 09/2015
1	Rheumatic Diseases (Rheumatism) 09/2015

Drug/Important Bio-Agent (IBA)

2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2019
1	Cell ExtractsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Monoclonal AntibodiesIBA 01/2021
1	aspartic acid glycine arginineIBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	IntegrinsIBA 01/2021
1	C-Type Lectins (C-Type Lectin)IBA 02/2020
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 09/2015
1	ProteomeIBA 09/2015
1	Biomarkers (Surrogate Marker)IBA 02/2010
1	AntibodiesIBA 05/2008
1	Cholecystokinin (Pancreozymin)IBA 05/2008
1	GastrinsIBA 05/2008
1	antigastrinIBA 05/2008

Therapy/Procedure

2	Therapeutics 05/2008 - 01/2005
1	Immunotherapy 05/2008